These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2140923)

  • 1. [Eradication of hepatitis B in Portugal. A challenge within reach of the National Health Service].
    Caetano JA
    Acta Med Port; 1990; 3(2):71-4. PubMed ID: 2140923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost-benefits of vaccination against hepatitis B in hospital personnel in Venezuela].
    Fernández Barboza R; Rivero D; Echeverría B; Machado IV
    Bol Oficina Sanit Panam; 1991 Jul; 111(1):16-23. PubMed ID: 1834080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis B among health workers].
    Miranda J; Cabezas C
    Rev Gastroenterol Peru; 2001; 21(2):128-35. PubMed ID: 12172565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Practical considerations of immunoprophylaxis in viral hepatitis].
    Nemesánszky E; Csepregi A
    Orv Hetil; 1998 Aug; 139(31):1835-42. PubMed ID: 9729677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Seroepidemiological study and program of vaccination against hepatitis B in school children in Extremadura].
    Gimeno Ortiz A; Jiménez Romano R; Zarallo Barbosa T
    Rev Sanid Hig Publica (Madr); 1993; 67(5):369-76. PubMed ID: 7732304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening and vaccination against hepatitis B among health personnel. Short-term results].
    Bertoglio C; Ariotti G; Demicheli V; Marino G; Piccinelli V; Leccardi E; Allosia GP; Corti E; Ballerini P
    Minerva Med; 1987 Apr; 78(8):537-42. PubMed ID: 2952903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of a health education program prior to a hepatitis B vaccination campaign among hospital personnel].
    Jaqueti Aroca J; Viña Simón C; Rodríguez Hodgson C; Maestre Sánchez E; Romero Martín M; Domínguez Carmona M
    Rev Sanid Hig Publica (Madr); 1991; 65(2):109-16. PubMed ID: 1839334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of early hepatitis B immunization programs for newborns and infants.
    Van Herck K; Van Damme P
    Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vaccine against hepatitis B. Comments apropos of a strategy].
    de Moura MC
    Acta Med Port; 1990; 3(2):67-8. PubMed ID: 2140922
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus genotypes: a South Pacific perspective.
    Harrison GL; Murray-McIntosh R; Penny D
    Pac Health Dialog; 2001 Mar; 8(1):188-92. PubMed ID: 12017822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on hepatitis B prevention. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Sep; 107(3):353-7. PubMed ID: 3039889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eight years of hepatitis B vaccination in Colombia with a recombinant vaccine: factors influencing hepatitis B virus infection and effectiveness.
    de la Hoz F; Perez L; de Neira M; Hall AJ
    Int J Infect Dis; 2008 Mar; 12(2):183-9. PubMed ID: 17913535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against hepatitis B virus infection in neonates.
    Pongpipat D; Suvatte V; Assateerawatts A
    Helv Paediatr Acta; 1984 Aug; 39(3):231-6. PubMed ID: 6242403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health control of HBV: worldwide HBV vaccination programme.
    Gust I
    Prog Clin Biol Res; 1991; 364():333-42. PubMed ID: 1826954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.